Filter
4934
Filtered Results: 4934
Text search:
medicines
availability
Featured
Recommendations
468
New Publications
1357
Language
Document type
No document type
2779
Studies & Reports
924
Guidelines
631
Manuals
238
Strategic & Response Plan
193
Fact sheets
58
Training Material
57
Situation Updates
34
Resource Platforms
8
Infographics
7
Brochures
3
Online Courses
2
Countries / Regions
India
238
Global
186
Kenya
167
Ethiopia
120
South Africa
116
Uganda
111
Nepal
107
Nigeria
100
Sierra Leone
99
Malawi
99
Liberia
94
Tanzania
87
Africa
86
Western and Central Europe
86
Bangladesh
72
Zambia
71
Myanmar / Burma
69
Latin America and the Carribbean
67
Ghana
62
Rwanda
62
Ukraine
53
Syria
50
Namibia
49
Philippines
42
Congo, Democratic Republic of
42
South–East Asia Region
41
Zimbabwe
38
Senegal
31
Lesotho
30
Guinea
30
Asia
29
East and Southern Africa
29
Eastern Europe
29
Mozambique
27
Haiti
26
West and Central Africa
25
Venezuela
24
Cambodia
23
Burkina Faso
21
Middle East and North Africa
21
Botswana
21
South Sudan
20
Cameroon
17
Indonesia
17
Eastern Europe and Central Asia
16
Brazil
15
Yemen
15
Russia
14
Eswatini/ Swaziland
14
Sudan
13
Afghanistan
12
Germany
12
Pakistan
12
Benin
11
Lebanon
11
Colombia
10
Thailand
10
USA
10
Moldova
10
Jordan
9
Western Pacific Region
9
North Macedonia
8
Somalia
8
Peru
7
Côte d’Ivoire / Ivory Coast
7
Georgia
7
Mali
7
Chile
6
Laos
6
North America
6
Vietnam
6
Central African Republic
6
Iraq
6
Ecuador
6
Tajikistan
5
Kazakhstan
5
Albania
5
Kyrgyzstan
5
Niger
5
Paraguay
5
Southern Africa
5
Sri Lanka
5
Poland
5
Burundi
4
Hungary
4
Libya
4
Madagascar
4
Mexico
3
Turkey
3
China
3
Morocco
3
Jamaica
3
Mauritius
3
Belarus
3
Bolivia
3
Argentina
3
Romania
3
Angola
3
Chad
3
El Salvador
2
Serbia
2
Togo
2
Iran
2
Canada
2
Qatar
2
Bulgaria
2
Mauritania
2
Gabon
2
Turkmenistan
2
Tunisia
2
United Kingdom
2
Portugal
2
Israel
2
Bosnia and Herzegovina
2
Papua New Guinea
2
Egypt
2
Palestine
2
Bhutan
2
Guatemala
2
Switzerland
1
Timor Leste/ East Timor
1
Australia
1
Gambia
1
Fiji
1
Estonia
1
Congo-Brazzaville
1
Uzbekistan
1
Malaysia
1
Austria
1
Mongolia
1
Italy
1
Armenia
1
Dominican Republic
1
Guinea-Bissau
1
Lithuania
1
Saudi Arabia
1
France
1
Maldives
1
Norway
1
Spain
1
Latvia
1
Nicaragua
1
Slovakia
1
Honduras
1
Solomon Islands
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
1977
Clinical Guidelines
415
Public Health
306
Women & Child Health
229
Key Resources
177
Capacity Building
81
Pharmacy & Technologies
62
Annual Report MEDBOX
2
Toolboxes
HIV
420
COVID-19
356
Mental Health
355
TB
263
AMR
214
Pharmacy
136
Planetary Health
135
NCDs
135
Caregiver
131
Disability
127
Rapid Response
124
NTDs
124
Conflict
122
Ebola
115
Global Health Education
70
Refugee
61
Natural Hazards
50
Health Financing Toolbox
38
Specific Hazards
22
Zika
22
Cholera
17
Social Ethics
11
Polio
11
Health Financing
1
Typhoon
1
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut...
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their income level and allocation of domestic resources to medicine and vaccine procurement. Access to safe a...
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine | The aim of this study was to explore the risk factors for stillbirth and neonatal death and change in perinatal outcomes after the introduction of helping Babies Breathe Quality Improvement Cycle in Nepal.
Haiti, one of the poorest countries in the world, was devastated by an earthquake in 2010. The disaster uncovered the realities of a non-existent mental health care system with only ten psychiatrists nationwide. Attempts were made to assess the increased prevalence of mental illness, likely due to t...
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us...
There is a substantial and ever-increasing unmet need for rehabilitation worldwide, which is particularly profound in low- and middle
-income countries. The availability of accessible and affordable rehabilitation is necessary for many people with health conditions to remain as independent as possi...
A nationwide survey of a representative sample of health facilities across public health services in all states and regions of Myanmar has been undertaken since 2014 to track Reproductive Health Commodity Security (RHCS) indicators, such as the availability of reproductive health (RH) commodities; t...
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis a...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
